Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Enhancement of xenograft tumor radiosensitivity by the histone deacetylase inhibitor MS-275 and correlation with histone hyperacetylationKevin Camphausen, Tamalee Scott, Mary Sproull, et al.International Journal of Radiation Oncology, Biology, Physics|January 31, 2004
In vivo tumor imaging using a near-infrared-labeled endostatin moleculeDeborah Citrin, Tamalee Scott, Mary Sproull, et al.Radiation Oncology (London, England)|August 26, 2009
High throughput evaluation of gamma-H2AXDane Avondoglio, Tamalee Scott, Whoon Jong Kil, et al.Bioorganic & Medicinal Chemistry|September 8, 2004
Evaluation of chelating agents as anti-angiogenic therapy through copper chelationKevin Camphausen, Mary Sproull, Steve Tantama, et al.Proceedings of the National Academy of Sciences of the United States of America|June 2, 2005
Influence of in vivo growth on human glioma cell line gene expression: convergent profiles under orthotopic conditionsKevin Camphausen, Benjamin Purow, Mary Sproull, et al.Cancer Research|November 17, 2005
Orthotopic growth of human glioma cells quantitatively and qualitatively influences radiation-induced changes in gene expressionKevin Camphausen, Benjamin Purow, Mary Sproull, et al.Molecular Cancer Therapeutics|April 14, 2004
In vivo tumor imaging in mice with near-infrared labeled endostatinDeborah Citrin, Andrew K Lee, Tamalee Scott, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2003
Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapyMala Chakraborty, Scott I Abrams, Kevin Camphausen, et al.Bioorganic & Medicinal Chemistry|September 3, 2003
Evaluation of copper chelation agents as anti-angiogenic therapyKevin Camphausen, Mary Sproull, Steve Tantama, et al.Journal of Cellular and Molecular Medicine|July 16, 2010
Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102Ian M Buchanan, Tamalee Scott, Anita T Tandle, et al.Pageof 2